Skip to main content


Figure 3 | Arthritis Research & Therapy

Figure 3

From: B cells in autoimmunity

Figure 3

CD27+ B cells with a memory phenotype are less susceptible to cyclophosphamide treatment in patients with systemic lupus erythematosus (SLE) (n = 20). Severely active SLE patients undergoing monthly intravenous cyclophosphamide bolus therapy were followed for a period of 3 to 6 months. Whereas CD27- B cells and CD27++ plasmablasts/plasma cells showed a decrease, the absolute numbers of CD27+ memory B cells did not change significantly. n.s., not significant.

Back to article page